CXCL9-expressing tumor-associated macrophages: new players in the fight against cancer by Shahram Salek-Ardakani, Paola Marie Marcovecchio, Graham Thomas

Get full text

Agonism of 4-1BB for immune therapy: a perspective on possibilities and complications by Shahram Salek-Ardakani, Dirk M. Zajonc, Michael Croft, Michael Croft

Get full text

OX40 facilitates control of a persistent virus infection. by Tobias Boettler, Friedrich Moeckel, Yang Cheng, Maximilian Heeg, Shahram Salek-Ardakani, Shane Crotty, Michael Croft, Matthias G von Herrath

Get full text

CD40 agonist-induced IL-12p40 potentiates hepatotoxicity by Wei Chen, Yan Qu, Shahram Salek-Ardakani, Graham Thomas, Jonathan Heyen, Javier Chaparro-Riggers, Caroline Bonnans, Wenqian He, Bernard Buetow, Min Liao, Breanna Jung, Smitha Pillai, Diane Matsumoto

Get full text

FcγRIIB engagement drives agonistic activity of Fc-engineered αOX40 antibody to stimulate human tumor-infiltrating T cells by Jie Wei, Shahram Salek-Ardakani, Wenjing Yang, Lucia Campos Carrascosa, Adriaan A van Beek, Valeska de Ruiter, Michail Doukas, Timothy S Fisher, Keith Ching, Karlijn van Loon, Patrick P C Boor, Yannick S Rakké, Lisanne Noordam, Pascal Doornebosch, Dirk Grünhagen, Kees Verhoef, Wojciech G Polak, Jan N M IJzermans, Irene Ni, Yik Andy Yeung, Dave Sprengers, Jaap Kwekkeboom

Get full text